Silibinin is a potent antiviral agent in patients with chronic hepatitis C not responding to pegylated interferon/ribavirin therapy. (Q42981378)
Jump to navigation
Jump to search
scientific article published on 3 August 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Silibinin is a potent antiviral agent in patients with chronic hepatitis C not responding to pegylated interferon/ribavirin therapy. |
scientific article published on 3 August 2008 |
Statements
Silibinin is a potent antiviral agent in patients with chronic hepatitis C not responding to pegylated interferon/ribavirin therapy (English)
Peter Ferenci
Thomas-Matthias Scherzer
Karoline Rutter
Sandra Beinhardt
Harald Hofer
Maximilian Schöniger-Hekele
Heidemarie Holzmann
Petra Steindl-Munda
3 August 2008